Computational Drug Discovery With Gain Therapeutics' Matthias Alder

We love to hear from our listeners. Send us a message. Gain Therapeutics' newly-appointed CEO Matthias Alder offers up a deep, yet abundantly clear explanation of how his company is applying compute power to speed up drug discovery. At Gain, computational models help researchers winnow down not just which molecules might have therapeutic effect, but also how adept those molecules will be at binding--and staying bound--to their target. It's not just theory, either. On this episode ...